IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tempest Therapeutics Inc (TPST)

CUSIP: 87978U207 | NYSE | Healthcare · Biotechnology | Micro Cap | 37 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AMatthew Angel5,531,51637.4%+694,446Mar 24, 2026No 13F filer matched
13D/AMatthew Angel5,531,516
37.4% of class · Mar 24, 2026

Institutional Holders — Q3 2026

Citigroup Inc15,426
0.0% of portfolio›$12.9K
StoneX Group Inc.13,668
0.0% of portfolio›$11.7K
SBI Securities Co., Ltd.56
0.0% of portfolio›$47
Parallel Advisors, LLC18
0.0% of portfolio›$15
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Citigroup Inc
15,426$12.9K0.0%CoreMediumNew York, NY2026-11-04
StoneX Group Inc.
13,668$11.7K0.0%ETFMediumNew York, NY2026-11-03
SBI Securities Co., Ltd.
56$470.0%Agg GrowthLowTokyo, Mexico2026-10-22
Parallel Advisors, LLC
18$150.0%IndexLowSan Francisco, CA2026-11-03
Caitong International Asset Management Co., Ltd
1$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
+694,446
No 13F filer matched